Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Serine and arginine rich splicing factor 10 pseudogene 1 (SRSF10P1)** is a human pseudogene with no evidence for translation into a functional protein. Pseudogenes like SRSF10P1 are evolutionary remnants of protein-coding genes and are commonly considered nonfunctional; however, some pseudogenes can have regulatory roles, such as acting as competing endogenous RNAs or affecting gene expression, though there is currently no evidence that SRSF10P1 plays such a role. This gene is not established as a therapeutic or diagnostic target, not classified within standard receptor, enzyme, transporter, or transcription factor families, and there are no known disease associations, functions, or drug interactions described for SRSF10P1[2][4]. There is also no strong evidence that SRSF10P1 is mis-annotated or misspelled, but functionally, it does not meet the criteria for a canonical molecular target due to its status as a pseudogene and lack of demonstrated biological or pharmacological activity. Its aliases include FUSIP1P, HsT2687, and SFRS13AP1[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serine and arginine rich splicing factor 10 pseudogene 1 (SRSF10P1).